Ribeiro, T.* ; Jónsdóttir, K.* ; Hernandez-Bautista, R. ; Silva, N.G.* ; Sánchez-Astráin, B.* ; Samadi, A.* ; Eiriksson, F.F.* ; Thorsteinsdóttir, M.* ; Ussar, S. ; Urbatzka, R.*
Metabolite profile characterization of cyanobacterial strains with bioactivity on lipid metabolism using in vivo and in vitro approaches.
Mar. Drugs 21:498 (2023)
Costa, M.* ; Rosa, F.* ; Ribeiro, T.* ; Hernandez-Bautista, R. ; Bonaldo, M.* ; Gonçalves Silva, N.* ; Eiríksson, F.* ; Thorsteinsdóttir, M.* ; Ussar, S. ; Urbatzka, R.*
Identification of cyanobacterial strains with potential for the treatment of obesity-related co- morbidities by bioactivity, toxicity evaluation and metabolite profiling.
Mar. Drugs 17:280 (2019)
Kremb, S.* ; Müller, C. ; Schmitt-Kopplin, P. ; Voolstra, C.R.*
Bioactive potential of marine macroalgae from the central red sea (Saudi Arabia) assessed by high-throughput imaging-based phenotypic profiling.
Mar. Drugs 15:E80 (2017)
O'Rourke, A.* ; Kremb, S.* ; Bader, T.M. ; Helfer, M. ; Schmitt-Kopplin, P. ; Gerwick, W.H.* ; Brack-Werner, R. ; Voolstra, C.R.*
Alkaloids from the sponge Stylissa carteri present prospective scaffolds for the inhibition of Human Immunodeficiency Virus 1 (HIV-1).
Mar. Drugs 14:28 (2016)
Jha, B.* ; Kavita, K.* ; Westphal, J. ; Hartmann, A. ; Schmitt-Kopplin, P.
Quorum sensing inhibition by Asparagopsis taxiformis, a marine macro alga: Separation of the compound that interrupts bacterial communication.
Mar. Drugs 11, 253-265 (2013)